Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit
1. Nexalin will be featured at the 2025 Maxim Growth Summit on October 22. 2. The company focuses on non-invasive neurostimulation for mental health treatment. 3. Nexalin's technology can penetrate deep brain structures with minimal side effects. 4. Their Gen-2 device is already approved in multiple countries, enhancing global prospects. 5. Engagement with industry leaders at the summit could boost visibility and opportunities.